 DURHAM, N.C.--BUSINESS WIRE--Aerie Pharmaceuticals, Inc. NASDAQ: AERI, an ophthalmic pharmaceutical company, today announced that it is executing its succession plan for its long-serving Chairman and CEO and that effective September 17, 2021, Vicente Anido, PhD. no longer serves as the Companys Chairman and Chief Executive Officer or as a director of the Company. Consistent with the succession plan in place, the Companys Board of Directors has appointed Benjamin F. McGraw, III, Pharm.D. a 